Information on the Target
The startup, LIFESCAPES, founded by Keio University, specializes in developing rehabilitation devices aimed at treating severe motor disabilities following a stroke. Leveraging advanced Brain-Machine Interface (BMI) technology cultivated over many years in Professor Junichi Ushiba's laboratory, LIFESCAPES aims to empower stroke patients to regain motor control over their paralyzed fingers using their own intent. This innovative approach focuses on detecting alternative neural pathways around the damaged circuits in the brain, enabling the reconstruction of connections between the brain and the impaired limbs.
With stroke identified as one of the five major diseases by the Ministry of Health, Labour and Welfare, there is a significant unmet medical need due to the lack of effective treatments for patients suffering from severe post-stroke motor impairments. LIFESCAPES' technology is gaining attention for its potential to improve patients' quality of life (QOL), making it a promising venture in the medical technology landscape.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
Japan's healthcare industry is undergoing significant transformation driven by technological advancement and an aging population. The government prioritizes addressing health issues prevalent among senior citizens, includ
Similar Deals
HCRx → CSL Vifor and Maruishi Pharmaceutical Co., Ltd.
2023
Nikon Corporation → Setsuro Tech Inc.
2023
Ricoh Lease Co., Ltd. → Feed Inc.
2023
Santen Pharmaceutical Co., Ltd. → Novagali Pharma S.A.
2023
JGC Holdings Corporation → Alpha Fusion
2023
JGC Holdings Corporation → TwoCells and MedRhythms Inc.
2021
Nikki Holdings
invested in
LIFESCAPES
in 2022
in a Corporate VC deal